These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28885659)

  • 1. The role of serum neuron-specific enolase in patients with prostate cancer: a systematic review of the recent literature.
    Muoio B; Pascale M; Roggero E
    Int J Biol Markers; 2018 Jan; 33(1):10-21. PubMed ID: 28885659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromogranin A and neurone-specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration-resistant prostate cancer.
    Fan L; Wang Y; Chi C; Pan J; Xun S; Xin Z; Hu J; Zhou L; Dong B; Xue W
    BJU Int; 2017 Aug; 120(2):226-232. PubMed ID: 28107595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer.
    Szarvas T; Csizmarik A; Fazekas T; Hüttl A; Nyirády P; Hadaschik B; Grünwald V; Püllen L; Jurányi Z; Kocsis Z; Shariat SF; Sevcenco S; Maj-Hes A; Kramer G
    BJU Int; 2021 Jan; 127(1):44-55. PubMed ID: 32314509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy.
    Kamiya N; Akakura K; Suzuki H; Isshiki S; Komiya A; Ueda T; Ito H
    Eur Urol; 2003 Sep; 44(3):309-14; discussion 314. PubMed ID: 12932928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapy.
    Heck MM; Thaler MA; Schmid SC; Seitz AK; Tauber R; Kübler H; Maurer T; Thalgott M; Hatzichristodoulou G; Höppner M; Nawroth R; Luppa PB; Gschwend JE; Retz M
    BJU Int; 2017 Jan; 119(1):30-37. PubMed ID: 27037533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Neuroendocrine Markers Predict Therapy Outcome of Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis.
    Liu Y; Zhao S; Wang J; Zhu Z; Luo L; Li E; Tang F; Zhao Z
    Urol Int; 2019; 102(4):373-384. PubMed ID: 30517936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Evaluation of Neuromediator Dynamics in Castration-Resistant Prostate Cancer Patients During Docetaxel.
    VON Hardenberg J; Schwartz M; Werner T; Fuxius S; Müller M; Frangenheim T; Bolenz C; Weiss C; Heinrich E
    Anticancer Res; 2017 Sep; 37(9):5117-5124. PubMed ID: 28870943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.
    Sainio M; Visakorpi T; Tolonen T; Ilvesaro J; Bova GS
    Pathol Res Pract; 2018 Jun; 214(6):848-856. PubMed ID: 29728311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
    Zhang L; Liu D; Li L; Pu D; Zhou P; Jing Y; Yu H; Wang Y; Zhu Y; He Y; Li Y; Zhao S; Qiu Z; Li W
    BMC Cancer; 2017 Feb; 17(1):96. PubMed ID: 28152979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma.
    Wibe E; Hannisdal E; Paus E; Aamdal S
    Eur J Cancer; 1992; 28A(10):1692-5. PubMed ID: 1389487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of abiraterone acetate on circulating neuromediators in chemotherapy-naïve castration-resistant prostate cancer.
    von Hardenberg J; Schwartz M; Werner T; Fuxius S; Müller M; Bolenz C; Weiß C; Heinrich E
    Prostate; 2016 May; 76(7):613-9. PubMed ID: 26779767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay.
    Tarle M; Radoś N
    Prostate; 1991; 19(1):23-33. PubMed ID: 1715080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron specific enolase and prognosis of non-small cell lung cancer: a systematic review and meta-analysis.
    Yan HJ; Tan Y; Gu W
    J BUON; 2014; 19(1):153-6. PubMed ID: 24659657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biomarkers in metastatic castration-resistant prostate cancer].
    Miller K
    Aktuelle Urol; 2015 Jan; 46(1):66-70. PubMed ID: 25658233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
    Taitou H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ookura H; Saijo N
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer.
    Huang Z; Xu D; Zhang F; Ying Y; Song L
    Clin Transl Oncol; 2016 Oct; 18(10):1019-25. PubMed ID: 26886220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron-specific enolase in testicular cancer--clinical experiences with serum neuron-specific enolase in patients with testicular cancer at diagnosis and during follow-up.
    Tandstad T; Klepp O
    Acta Oncol; 2003; 42(3):202-6. PubMed ID: 12852696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine serum tumour markers in hormone-resistant prostate cancer.
    Hvamstad T; Jordal A; Hekmat N; Paus E; Fosså SD
    Eur Urol; 2003 Aug; 44(2):215-21. PubMed ID: 12875941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuron-specific enolase--a serum tumour marker in seminoma?
    Fosså SD; Klepp O; Paus E
    Br J Cancer; 1992 Feb; 65(2):297-9. PubMed ID: 1739633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuron specific enolase (NSE) in serum of patients with malignant melanoma.
    Wibe E; Paus E; Aamdal S
    Cancer Lett; 1990 Jun; 52(1):29-31. PubMed ID: 2354416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.